Cite
Use of cholesterol‐lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink.
MLA
Zamani, Shahriar A., et al. “Use of Cholesterol‐lowering Medications in Relation to Risk of Primary Liver Cancer in the Clinical Practice Research Datalink.” Cancer (0008543X), vol. 130, no. 20, Oct. 2024, pp. 3506–18. EBSCOhost, https://doi.org/10.1002/cncr.35436.
APA
Zamani, S. A., Graubard, B. I., Hyer, M., Carver, E., Petrick, J. L., & McGlynn, K. A. (2024). Use of cholesterol‐lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer (0008543X), 130(20), 3506–3518. https://doi.org/10.1002/cncr.35436
Chicago
Zamani, Shahriar A., Barry I. Graubard, Marianne Hyer, Emily Carver, Jessica L. Petrick, and Katherine A. McGlynn. 2024. “Use of Cholesterol‐lowering Medications in Relation to Risk of Primary Liver Cancer in the Clinical Practice Research Datalink.” Cancer (0008543X) 130 (20): 3506–18. doi:10.1002/cncr.35436.